With the introduction of Hyogen®, a Mycoplasma hyopneumoniae bacterin, we will inspire veterinarians to achieve more effective immunity, thus giving pigs superior enzootic pneumonia protection. With Ceva’s innovative adjuvant, Imuvant™, pigs benefit from more complete, fast and long lasting protection from both clinical and subclinical enzootic pneumonia, leading to greater profitability from one shot of Hyogen®.
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.